Condition

Macular Telangiectasia Type 2

Treatments and trials tagged Macular Telangiectasia Type 2, with the same country and access zoom as New Developments.

All New Developments

Macular Telangiectasia Type 2 breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

First FDA-Approved Implant Treatment for MacTel Eye Disease

Encelto (revakinagene taroretcel-lwey) — encapsulated cell implant for macular telangiectasia type 2

FDA approval on 5 March 2025 for Encelto (revakinagene taroretcel-lwey) implant — an allogeneic encapsulated cell-based gene therapy for…

This is for adults living with idiopathic macular telangiectasia type 2 — and the caregivers who help them —…